Seminars in Nephrology
Volume 30, Issue 1 , Pages 33-41 , January 2010

Population-Based Interventions To Reduce Socioeconomic Disparities in Chronic Kidney Disease

  • William M. McClellan, MD

      Affiliations

    • Departments of Medicine and Epidemiology, Emory University, Atlanta, GA
    • Georgia Medical Care Foundation, Atlanta, GA
    • Corresponding Author InformationAddress reprint requests to William McClellan, MD, MPH, Emory University, 1518 Clifton Rd, Atlanta, GA, 30322
    • ,
  • Mary Teresa Casey, RD, LD

      Affiliations

    • Division of Quality Improvement Policy for Chronic and Ambulatory Care, Centers for Medicare & Medicaid Services, Baltimore, MD
    • ,
  • JoVonn Hughley, MPH

      Affiliations

    • Georgia Medical Care Foundation, Atlanta, GA
    • ,
  • Eugene Freund, MD, MSPH, CAPT, USPHS

      Affiliations

    • Division of Quality Improvement Policy for Chronic and Ambulatory Care, Centers for Medicare & Medicaid Services, Baltimore, MD

References 

  1. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1–S266
  2. Vassalotti JA, Stevens LA, Levey AS. Testing for chronic kidney disease: a position statement from the National Kidney Foundation. Am J Kidney Dis. 2007;50:169–180
  3. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–2572
  4. American Diabetes Association. Standards of medical care in diabetes—2006. Diabetes Care. 2006;29:S1–S71
  5. National Kidney Foundation. K/DOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis. 2007;49:S1–S180
  6. National Kidney Foundation. K/DOQI clinical practice guidelines for hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004;43:S1–S290
  7. US Renal Data System. USRDS 2007 annual data report: atlas of end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2007;
  8. Marmot MG. Understanding social inequalities in health. Perspect Biol Med. 2003;46(Suppl):S9–S23
  9. Kitagawa EM, Hauser PM. Differential mortality in the United States: a study in socioeconomic epidemiology. Cambridge, MA: Harvard University Press; 1973;
  10. Minkler M, Fuller-Thomson E, Guralnik JM. Gradient of disability across the socioeconomic spectrum in the United States. N Engl J Med. 2006;355:695–703
  11. Owen WF, Szczech LA, Frankenfield DL. Healthcare system interventions for inequality in quality: corrective action through evidence-based medicine. J Natl Med Assoc. 2002;94(Suppl):83S–91S
  12. Fiscella K, Franks P, Gold MR, Clancy CM. Inequality in quality: addressing socioeconomic, racial, and ethnic disparities in health care. JAMA. 2000;283:2579–2584
  13. Norris K, Nissenson AR. Race, gender, and socioeconomic disparities in CKD in the United States. J Am Soc Nephrol. 2008;19:1261–1270
  14. Rostand SG, Brown G, Kirk KA, Rutsky EA, Dustan HP. Renal insufficiency in treated essential hypertension. N Engl J Med. 1989;320:684–688
  15. Rostand SG. US minority groups and end-stage renal disease: a disproportionate share. Am J Kidney Dis. 1992;19:411–413
  16. Brancati FL, Whittle JC, Whelton PK, Seidler AJ, Klag MJ. The excess incidence of diabetic end-stage renal disease among blacks (A population-based study of potential explanatory factors). JAMA. 1992;268:3079–3084
  17. Whittle JC, Whelton PK, Seidler AJ, Klag MJ. Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease?. Arch Intern Med. 1991;151:1359–1364
  18. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Stamler J. End-stage renal disease in African-American and white men (16-year MRFIT findings). JAMA. 1997;277:1293–1298
  19. Perneger TV, Whelton PK, Klag MJ. Race and end-stage renal disease (Socio-economic status and access to health care as mediating factors). Arch Intern Med. 1995;155:1201–1208
  20. Ward MM. Socioeconomic status and the incidence of ESRD. Am J Kidney Dis. 2008;51:563–572
  21. Young EW, Mauger EA, Jiang KH, Port FK, Wolfe RA. Socioeconomic status and end-stage renal disease in the United States. Kidney Int. 1994;45:907–911
  22. Byrne C, Nedelman J, Luke RG. Race, socioeconomic status, and the development of end-stage renal disease. Am J Kidney Dis. 1994;23:16–22
  23. Volkova N, McClellan W, Klein M, Flanders D, Kleinbaum D, Soucie JM, et al. Neighborhood poverty and racial differences in ESRD incidence. J Am Soc Nephrol. 2008;19:356–364
  24. Hunsicker LG, Adler S, Caggiula A, England BK, Greene T, Kusek JW, et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int. 1997;51:1908–1919
  25. White SL, McGeechan K, Jones M, Cass A, Chadban SJ, Polkinghorne KR, et al. Socioeconomic disadvantage and kidney disease in the United States, Australia, and Thailand. Am J Public Health. 2008;98:1306–1313
  26. Martins D, Tareen N, Zadshir A, Pan D, Vargas R, Nissenson A, et al. The association of poverty with the prevalence of albuminuria: data from the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis. 2006;47:965–971
  27. Nickolas TL, Frisch GD, Opotowsky AR, Arons R, Radhakrishnan J. Awareness of kidney disease in the US population: findings from the National Health and Nutrition Examination Survey (NHANES) 1999 to 2000. Am J Kidney Dis. 2004;44:185–197
  28. Waterman AD, Browne T, Waterman BM, Gladstone EH, Hostetter T. Attitudes and behaviors of African Americans regarding early detection of kidney disease. Am J Kidney Dis. 2008;51:554–562
  29. Rodriguez RA, Sen S, Mehta K, Moody-Ayers S, Bacchetti P, O'Hare AM. Geography matters: relationships among urban residential segregation, dialysis facilities, and patient outcomes. Ann Intern Med. 2007;146:493–501
  30. Diez-Roux AV. Bringing context back into epidemiology: variables and fallacies in multilevel analysis. Am J Public Health. 1998;88:216–222
  31. Braveman PA, Cubbin C, Egerter S, Chideya S, Marchi KS, Metzler M, et al. Socioeconomic status in health research: one size does not fit all. JAMA. 2005;294:2879–2888
  32. Krieger N, Williams DR, Moss NE. Measuring social class in US public health research: concepts, methodologies, and guidelines. Annu Rev Public Health. 1997;18:341–378
  33. Kuh D, Ben-Shlomo Y, Lynch J, Hallqvist J, Power C. Life course epidemiology. J Epidemiol Community Health. 2003;57:778–783
  34. Shoham DA, Vupputuri S, Kshirsagar AV. Chronic kidney disease and life course socioeconomic status: a review. Adv Chronic Kidney Dis. 2005;12:56–63
  35. Merkin SS, Coresh J, Roux AV, Taylor HA, Powe NR. Area socioeconomic status and progressive CKD: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2005;46:203–213
  36. Merkin SS, Roux AV, Coresh J, Fried LF, Jackson SA, Powe NR. Individual and neighborhood socioeconomic status and progressive chronic kidney disease in an elderly population: the Cardiovascular Health Study. Soc Sci Med. 2007;65:809–821
  37. Shoham DA, Vupputuri S, Diez Roux AV, Kaufman JS, Coresh J, Kshirsagar AV, et al. Kidney disease in life-course socioeconomic context: the Atherosclerosis Risk in Communities (ARIC) study. Am J Kidney Dis. 2007;49:217–226
  38. Shoham DA, Vupputuri S, Kaufman JS, Kshirsagar AV, Diez Roux AV, Coresh J, et al. Kidney disease and the cumulative burden of life course socioeconomic conditions: the Atherosclerosis Risk in Communities (ARIC) study. Soc Sci Med. 2008;67:1311–1320
  39. Blagg CR. The early history of dialysis for chronic renal failure in the United States: a view from Seattle. Am J Kidney Dis. 2007;49:482–496
  40. Evans RW, Blagg CR, Bryan FA. Implications for health care policy: a social and demographic profile of hemodialysis patients in the United States. JAMA. 1981;245:487–491
  41. In:  Rettig PA,  Levinsky NG editor. Institute of Medicine: kidney failure and the federal government. Washington, DC: National Academy Press; 1991;
  42. Levinsky NG. The organization of medical care (Lessons from the Medicare end stage renal disease program). N Engl J Med. 1993;329:1395–1399
  43. Sehgal AR. Impact of quality improvement efforts on race and sex disparities in hemodialysis. JAMA. 2003;289:996–1000
  44. Agency for Healthcare Research and Quality. 2007 national healthcare disparities report. Rockville, MD: U.S. Department of Health and Human Services, Agency for Healthcare Research and Quality; 2008;AHRQ Pub. No. 08-0041. [Accessed 2009 Nov 13] www.ahrq.gov/qual/nhdr07/nhdr07.pdf
  45. McClellan WM, Wasse H, McClellan AC, Kipp A, Waller LA, Rocco MV. Treatment center and geographic variability in pre-ESRD care associate with increased mortality. J Am Soc Nephrol. 2009;20:1078–1085
  46. Accetta NA, Gladstone EH, DiSogra C, Wright EC, Briggs M, Narva AS. Prevalence of estimated GFR reporting among US clinical laboratories. Am J Kidney Dis. 2008;52:778–787
  47. Duffy FD, Lynn LA, Didura H, Hess B, Caverzagie K, Grosso L, et al. Self-assessment of practice performance: development of the ABIM Practice Improvement Module (PIM). J Contin Educ Health Prof. 2008;28:38–46
  48. Freedman BI, Volkova NV, Satko SG, Krisher J, Jurkovitz C, Soucie JM, et al. Population-based screening for family history of end-stage renal disease among incident dialysis patients. Am J Nephrol. 2005;25:529–535
  49. Jurkovitz C, Hylton TN, McClellan WM. Prevalence of family history of kidney disease and perception of risk for kidney disease: a population-based study. Am J Kidney Dis. 2005;46:11–17
  50. Jurkovitz C, Franch H, Shoham D, Bellenger J, McClellan W. Family members of patients treated for ESRD have high rates of undetected kidney disease. Am J Kidney Dis. 2002;40:1173–1178
  51. Brown WW, Peters RM, Ohmit SE, Keane WF, Collins A, Chen SC, et al. Early detection of kidney disease in community settings: the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2003;42:22–35
  52. Georgia Department of Human Resources. Division of Public Health - 2 Peachtree Street, NW - Atlanta, GA 30303 - (404) 657-3103 ga-diabetes@dhr.state.ga.ushttp://health.state.ga.us[accessed 2009 Nov 13]
  53. McClellan WM, Wasse H, McClellan AC, Kipp A, Waller LA, Rocco MV. Treatment center and geographic variability in pre-ESRD care associate with increased mortality. J Am Soc Nephrol. 2009;20:1078–1085

 The views expressed in this article are those of the authors and do not necessarily reflect official policy of the Centers for Medicare & Medicaid Services.

PII: S0270-9295(09)00177-6

doi: 10.1016/j.semnephrol.2009.10.011

Seminars in Nephrology
Volume 30, Issue 1 , Pages 33-41 , January 2010

Article Tools

* Image Usage & Resolution